CHDI Foundation
The CHDI Foundation, Inc., is a United States–based non-profit biomedical foundation that aims to "rapidly discover and develop drugs that delay or slow the progression of Huntington's disease", a neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for CHDI Foundation, United States, covering academic research published from 2005 to 2024. Read More.
Open Access Percentage
57%
Total
Publications
575
Total Open
Publications
326
Total
Citations
28K
Open Access
Percentage
57%
Total
Publications
575
Total Open
Publications
326
Total
Citations
28K
Breakdown
Publisher Open
10%
Both
31%
Other Platform Open
13%
Closed
46%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 62%
137
Hybrid 17%
38
No Guarantees 21%
45
Other Platform Open
Domain 85%
209
Institution 24%
59
Other Internet 12%
30
Public 8%
19
Preprint 1%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 208 |
DOI | Other Internet | 27 |
Europe PMC | Domain | 22 |
Figshare | Public | 16 |
University of Cambridge - Apollo | Institution | 7 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 6 |
DANS - Data Archiving and Networked Services | Institution | 6 |
universiteitleiden.nl OAI-PMH Repository | Institution | 5 |
DASH - Digital Access to Scholarship at Harvard | Institution | 5 |
Zenodo | Public | 4 |